Clinical Trials Logo

Clinical Trial Summary

The investigators propose that Arterial Spin Labelling Functional Magnetic Imaging will be able to capture functional changes associated with caloric vestibular stimulation and better delineate the etiology of the pain augmentation that has been documented with this intervention.


Clinical Trial Description

There has been recent success in utilizing the non-invasive caloric vestibular stimulation as a means of modulating chronic pain. Caloric stimulation involves cooling the ear canal with either water or a cooling probe to induce vestibular stimulation. This is a technique frequently performed as part of a neurologic exam.

The current theory of how caloric vestibular stimulation regulates pain is by thermosensory disinhibition. Temperatures below 25 C activate both cold thermoreceptors (Aδ fibers) and also C-nociceptors. These inputs pass in the spinothalamic tract to the thalamus, where the C-fiber input goes to the anterior cingulate cortex (ACC) and the Aδ fiber input passes to the thermosensory cortex in the dorsal posterior insula (dpIns). It is proposed that CVS reduces central pain by activating the parieto-insular vestibular cortex. As this area is anatomically adjacent to dorsal posterior insula, it may cross-activate it to suppress the ACC, or given both these cortical areas share pathways in the brainstem this may be the mechanism by which pain is suppressed.

Our team has successfully demonstrated arterial spin labeling (ASL), among other functional magnetic resonance imaging modalities, to capture functional changes in cerebral processing related to pain. This utilizes the principle that increases in cerebral blood flow to a specific region of the cortex is a marker for increased functioning of this region, conversely a decrease of blood flow to a specified region is a correlate of down regulation of this specific region. We propose that ASL will be able to capture functional changes associated with caloric vestibular stimulation and better delineate the etiology of the pain augmentation.

All functional studies will be conducted on a 3 Tesla scanner equipped with an 8-element, receive-only head coil. Each subject will lay in a supine position on the MRI table with their head immobilized by foam padding and a chinstrap. Every study will begin by collecting high-resolution anatomical images using a three-dimensional spoiled GRASS (Gradient Recalled Acquisition in Steady State) sequence. These structural images will be used for placement of the functional images and for anatomical atlas transformation in the image processing. The perfusion-weighted images will be acquired with a pulsed arterial spin labeling (non-invasive) approach. Once the baseline perfusion weighted functional images have been attained a continual functional image acquisition sequence will begin. During this phase the subject will have a series of three 30 second cooled ear canal irrigations separated by 60 seconds. The water will be cooled to 18 degrees Celsius using an ice water combination and standard thermometer. The irrigation will be administered at 2cc per second (total of 30cc per ear over 30 seconds) via an MRI compatible infusion pump through a modified stethoscope with perforations to ensure there is no possibility of pressure build-up within the canal. Following this series, perfusion weighted images will be collected for a subsequent 10minutes. Subjects will be welcome to discontinue from the study at any time they see fit. Each functional study will comprise 24.5 minutes. 10 minutes of baseline imaging 5.5 minutes of initial functional imaging, 4.5 min of caloric vestibular stimulation and 5.5 minutes of repeat functional imaging.

Images are to be reconstructed using software written in IDL (Interactive Data Language, Research Systems, Boulder, CO). Functional image pre-processing and statistical analyses will be performed with Statistical Parametric Mapping software (SPM2, Wellcome Department of Imaging Neuroscience, University College London, UK, http://www.fil.ion.ucl.ac.uk/spm). The end data will be a measurement, in percentage change, of blood flow to specific anatomic regions of the cortex. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01659073
Study type Interventional
Source Lawson Health Research Institute
Contact
Status Completed
Phase N/A
Start date September 9, 2012
Completion date September 30, 2013

See also
  Status Clinical Trial Phase
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A